Hong‐Fei Yao

430 citations
26 papers · 262 indexed · h-index 9
Topics
Pancreatic and Hepatic Oncology Research (9 papers)RNA modifications and cancer (7 papers)Cancer, Hypoxia, and Metabolism (6 papers)
Partner nations
ChinaUnited Kingdom

In The Last Decade

Hong‐Fei Yao

22 papers receiving 262 citations

Peers

Hong‐Fei Yao
Comparison fields: 5 of 53
  • Oncology 118
  • Molecular Biology 88
  • Cancer Research 79
  • Immunology 56
  • Pulmonary and Respiratory Medicine 49
Replace Ryann E. Shor with:
Ryann E. Shor United States
William J. Kaliney United States
Seog Young Kim South Korea
Diane Costanzo-Garvey United States
Margarita Bartish Sweden
Zhenzhen Fan China
Ramon M. Cabrera United States
Jennifer Kleponis United States
Donger Zhou China
Yuansong Bai China
Hong‐Fei Yao relative to Ryann E. Shor United States Ryann E. Shor's profile →
Citations per field
00.5×2.9×
Ryann E. Shor · 1×
Citations per year

Countries citing papers authored by Hong‐Fei Yao

Since Specialization
Citations

This map shows the geographic impact of Hong‐Fei Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Fei Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Fei Yao more than expected).

Fields of papers citing papers by Hong‐Fei Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Fei Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Fei Yao. The network helps show where Hong‐Fei Yao may publish in the future.

Co-authorship network of co-authors of Hong‐Fei Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Fei Yao. A scholar is included among the top collaborators of Hong‐Fei Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Fei Yao. Hong‐Fei Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 0
3 5
4 0
5 3
6 30
7 5
8 1
9 7
10 3
11 18
12 2
13 3
14 15
15 9
16 23
17 6
18 63
19 10
20 24

About Hong‐Fei Yao

Hong‐Fei Yao is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 262 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), RNA modifications and cancer (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Cancer Research (79 citations), Oncology (118 citations) and Immunology (56 citations). Hong‐Fei Yao has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Yan‐Miao Huo, Yongwei Sun, Shu-Heng Jiang, Dejun Liu, Jian Yang, Minwei Yang, Chongyi Jiang, Xiaoyan Tang, Chunjing Li and Ling‐Ye Tao. Their work appears in journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026